Delivery Order SPE2DB22D1106-SPE2DB25FEUA1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a $1,023.75 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed in Conshohocken, Pennsylvania. The order represents a delivery against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $1,048.48 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.75 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML in dextrose solution. The contract employs firm fixed price terms and is scheduled for ultimate completion on July 30, 2025, just one day after the award date of July 29, 2025. This delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,612.07 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextroses, an antibiotic pharmaceutical product. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and utilizes firm fixed pricing. The contract was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50mL with dextrose, an antibiotic pharmaceutical product. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,253.40 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. This competitive, firm fixed-price delivery order was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a non-set-aside award, this contract was competed among qualified vendors capable...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUA1Delivery Order
The Defense Logistics Agency awarded a $1,228.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML-Dextrose, a pharmaceutical product used in military and federal healthcare systems. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates the contractor's ongoing role as a primary pharmaceutical supplier within the DLA's medical supply chain for federal procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/18/25 |